600594.SS
Guizhou Yibai Pharmaceutical Co., Ltd. [600594.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
600594.SS Stock Summary
Top 10 Correlated Stocks
600594.SS
In the News
600594.SS Financial details
Company Rating
-
Market Cap
3.73B
Income
-462.71M
Revenue
2.77B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
5.56K
Optionable
No
Shortable
Yes
Earnings
19 Apr 2024
P/E
-9.63
Forward P/E
-
PEG
0.33
P/S
1.61
P/B
1.39
P/C
-
P/FCF
-5.69
Quick Ratio
1.44
Current Ratio
2.32
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.58
EPS next Y
-
EPS next Q
-
EPS this Y
-277.42%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-9.78%
Revenue last 5Y
-6.77%
Revenue Q/Q
-17.44%
EPS Q/Q
-51.82%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-9%
ROE
-15%
ROC
-0.11%
Gross Margin
69%
Oper. Margin
-15%
Profit Margin
-17%
Payout
-9%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.8-6.35
52W High
-31%
52W Low
+38%
RSI
47
Rel Volume
1.21
Avg Volume
12.07M
Volume
14.58M
Perf Week
-0.72%
Perf Month
-3.72%
Perf Quarter
-0.72%
Perf Half Y
-2.13%
-
-
-
-
Beta
0.418
-
-
Volatility
0.04%, 0.1%
Prev Close
1.72%
Price
4.14
Change
0.73%
Company Profile
- Volume Average 12.07M
- Market Capitalization 3.73B
- Employee 5.56K
- CEO Ms. Ya Qi Dou
- Headquarters Guiyang,CN
- IPO Date 2004-03-23
-
Website
https://www.gzcci.com 
Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatism, digestive system, pediatric, gynecological, anti-infection, anti-inflammatory, analgesic, and other diseases. The company was founded in 1995 and is based in Guiyang, China.
